Figure 2. Risk of Developing Subsequent Primary Cancers Among 5-Year Female Cancer Survivors.

See the legend to Figure 1 for a description of the methods used to calculate the contribution of each cell to total incidence of subsequent primary cancer (A) and the standardized incidence ratios (B) as well as definitions of abbreviations. See Supplement 1 for point estimates and excess absolute incidences. NOS indicates not otherwise specified; t indicates tamoxifen.